Antitumor mechanisms of attenuated Salmonella typhimurium containing the gene for human interleukin-2: A novel antitumor agent?

Journal of Pediatric Surgery

Volumn 32, Issue 2, 1997, Pages 301-306

  Saltzman, Daniel A ^a   Katsanis, Emmanuel ^b   Heise, Charles P ^b   Hasz, Diane E ^b   Vigdorovich, Vladimir ^b   Kelly, Sandra M ^b   Curtiss III, Roy ^b   Leonard, Arnold S ^b   Anderson, Peter M ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

Avirulent salmonella; biotherapy; hepatic malignancy; interleukin 2

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ATTENUATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; FEMALE; GENE TARGETING; HELPER CELL; KUPFFER CELL; LIVER METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SUPPRESSOR CELL;

EID: 0031044363     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(97)90198-6     Document Type: Conference Paper

References (25)

1. Blumgart LH, Fong Y: Surgical options in the treatment of hepatic metastases from colorectal cancer. Curr Prob Surg 32:333-428, 1995
2. Anderson PM, Sorenson MA: Interleukin-2: Effects of route and formulation on clinical pharmacokinetics. Clin Pharmacokinet 27:19-31, 1994
3. Whittington R, Faulds D: Interleukin-2: A review of its pharmacologie properties and therapeutic use in patients with cancer. Drugs 46:446-514, 1993
4. Vial T, Descotes J: Clinical toxicity of interleukin-2. Drug Safety 7.417-433, 1992
5. Dunlap NE, Benjamin Jr WH, McCall Jr RD, et al: A 'safe-site' of Salmonella typhimurium is within splenic cells during the early phase of infection in mice. Microb Pathog 10:291-310, 1991
6. Curtiss R III, Kelly SM: Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect Immun 55:3035-3043, 1987
7. Saltzman DA. Heise CP, Hasz DE, et al: Attenuated Salmonella typhimurium containing interleukin-2 decreases MC-38 hepatic metastases: A novel anti-tumor agent. Cancer Biother Radiopharm 11:145-153, 1996
8. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY. Cold Spring Harbor Laboratory Press, 1989
9. Lafreniere R, Rosenberg SA: A novel approach to the generation and identification of hepatic metastases in a murine model. JNCI 76:309-322, 1986
10. Dialynas DP, Quan ZS, Wall KA, et al: Characterization of murine T cell surface molecule designated L3T4, identified by monoclonal antibody GK1.5: Similarity of L3T4 to human Leu3/T4 molecule. J Immunol 131:2445-2451, 1983
11. Sarmiento M, Glasebrook AL, Fitch FW- IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell mediated cytolysis in the absence of complement. J Immunol 125:2665-2672, 1980
12. Kasia M, Iwamori M, Nagai Y, et al: A Glycolipid on the Surface of Mouse Natural Killer Cells. Eur J Immunol 10:17-180, 1980
13. Hardonk MJ, Dijkhuis FWJ, Hulstaert CE, et al: Heterogeneity of rat liver and spleen macrophages in gadolinium chloride induced elimination and repopulation. J Leukoc Biol 52:296-302, 1992
14. Iwanuma Y, Kato K, Yagita H, et al. Induction of tumor-specific cytotoxic T lymphocytes and natural killer cells by tumor cells transfected with the interleukin-2 gene. Cancer Immunol Immunother 40:17-23, 1995
15. Smith K: Lowest dose interleukin-2 immunotherapy. Blood 81:1414-1423, 1993
16. Kintzel PE, Calls KA: Recombinant Interleukin-2: A biological response modifier. Clin Pharm 10:110-128, 1991
17. + tumor-infiltrating lymphocytes. J Exp Med 173:647-658, 1991
18. Richman LK, Klingenstein RJ, Richman JA, et al: The murine Kupffer cell: Characterization of the cell serving accessory function in antigen specific T cell proliferation. J Immunol 123:2602-2609, 1979
19. Nalue N, Shnyra A, Hultenby K, et al: Salmonella choleraesuis and Salmonella typhimurium associated with liver cells after intravenous inoculation of rats are localized mainly in Kupffer cells and multiply intracellularly. Infect Immun 60:2758-2768, 1992
20. Conlan JA, North RJ: Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes. Infect Immun 60:5164-5171, 1992
21. Ettinghausen SE, Lipford III EH, Mule JJ, et al: Systemic administration of recombinant IL-2 stimulates in vivo lymphoid cell proliferation in tissues. J Immunol 135:1488-1497, 1985
22. Lafreniere R, Borkenhagen K, Bryant LD, et al: Analysis of liver lymphoid cell subsets pre- and post in vivo administration of human recombinant IL-2 in a c57BL/6 system. Cancer Res 50:1658-1666, 1990
23. Hopkins S, Kraehenbuhl JP, Schodel F, et al: A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect Immun 63:3279-3286, 1995
24. Schodel F, Kelly SM, Peterson DL, et al: Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination. Infect Immun 62:1669-1676, 1994
25. Tacket CO, Hone DM, Curtiss III R, et al: Comparison of the safety and immunogenicity of ΔaroC ΔaroD and Δcya Δcrp Salmonella typhi strains in adult volunteers. Infect Immun 60:536-541, 1992